[Not Available].
作者信息
Yaseen Wid, Auguste Bourne, Zipursky Jonathan
机构信息
Département de médecine (Yaseen, Auguste, Zipursky), Université de Toronto; Divisions de néphrologie (Auguste) et de pharmacologie clinique et toxicologie (Zipursky), Centre des sciences de la santé Sunnybrook, Toronto, Ont.
出版信息
CMAJ. 2023 Jul 17;195(27):E944. doi: 10.1503/cmaj.221575-f.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]。
CMAJ. 2023 Jul 17;195(27):E944. doi: 10.1503/cmaj.221575-f.
2
Allopurinol hypersensitivity syndrome.别嘌醇超敏综合征。
CMAJ. 2023 Apr 3;195(13):E483. doi: 10.1503/cmaj.221575.
3
[Allopurinol hypersensitivity syndrome. A report of two cases].[别嘌醇超敏综合征。两例报告]
Rev Med Inst Mex Seguro Soc. 2016 Mar-Apr;54(2):261-4.
4
Cerebral vasculitis and multi-focal neurological deficits due to allopurinol-induced hypersensitivity syndrome.别嘌醇诱发的超敏反应综合征所致的脑血管炎和多灶性神经功能缺损
Australas J Dermatol. 2014 Feb;55(1):84-7. doi: 10.1111/ajd.12016. Epub 2013 Jan 18.
5
HLA-B*5801 Testing to Prevent Allopurinol Hypersensitivity Syndrome: A Teachable Moment.检测HLA - B*5801以预防别嘌醇超敏反应综合征：一个值得汲取经验的时刻。
JAMA Intern Med. 2018 Sep 1;178(9):1260-1261. doi: 10.1001/jamainternmed.2018.3556.
6
Allopurinol induced DRESS syndrome without eosinophilia and pronounced mucosal involvement.
J Eur Acad Dermatol Venereol. 2016 May;30(5):865-7. doi: 10.1111/jdv.13033. Epub 2015 Feb 17.
7
Allopurinol Induced DRESS Syndrome.别嘌醇诱发的药物超敏反应伴嗜酸性粒细胞增多和系统症状综合征
J Assoc Physicians India. 2014 Nov;62(11):63-5.
8
HLA-B*5801: a genetic susceptibility to allopurinol-induced DRESS.HLA - B*5801：别嘌醇诱导的药物超敏反应伴嗜酸性粒细胞增多和系统症状（DRESS）的遗传易感性。
Med J Aust. 2016 Mar 7;204(4):159-60. doi: 10.5694/mja15.01113.
9
Allopurinol-induced DRESS syndrome with a histologic pattern consistent with interstitial granulomatous drug reaction.别嘌醇诱发的药物超敏反应伴嗜酸性粒细胞增多和系统症状（DRESS）综合征，组织学表现符合间质性肉芽肿性药物反应。
Am J Dermatopathol. 2014 Feb;36(2):193-6. doi: 10.1097/DAD.0b013e3181c0e14d.
10
[Allopurinol-induced DRESS complicated by hemophagocytic lymphohistiocytosis].[别嘌醇诱发的药物超敏反应伴噬血细胞性淋巴组织细胞增生症]
Ann Dermatol Venereol. 2015 Dec;142(12):767-70. doi: 10.1016/j.annder.2015.03.026. Epub 2015 May 14.
本文引用的文献
1
Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study.心脏病与别嘌醇相关严重皮肤不良反应风险：一项基于普通人群的队列研究。
CMAJ. 2019 Sep 30;191(39):E1070-E1077. doi: 10.1503/cmaj.190339.
2
HLA-B*5801 Testing to Prevent Allopurinol Hypersensitivity Syndrome: A Teachable Moment.检测HLA - B*5801以预防别嘌醇超敏反应综合征：一个值得汲取经验的时刻。
JAMA Intern Med. 2018 Sep 1;178(9):1260-1261. doi: 10.1001/jamainternmed.2018.3556.
3
Allopurinol hypersensitivity: investigating the cause and minimizing the risk.别嘌醇超敏反应：探究病因并降低风险。
Nat Rev Rheumatol. 2016 Apr;12(4):235-42. doi: 10.1038/nrrheum.2015.132. Epub 2015 Sep 29.
4
Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.临床药物遗传学实施联盟 HLA-B 基因型和别嘌醇剂量指南。
Clin Pharmacol Ther. 2013 Feb;93(2):153-8. doi: 10.1038/clpt.2012.209. Epub 2012 Oct 17.
5
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.2012年美国风湿病学会痛风管理指南。第1部分：高尿酸血症的系统性非药物和药物治疗方法。
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1431-46. doi: 10.1002/acr.21772.
Zotero 插件